Xencor doses first subject in early-stage XmAB564 autoimmune disease study
29 April 2021 - 6:19AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From May 2024 to May 2024
Xencor (NASDAQ:XNCR)
Historical Stock Chart
From May 2023 to May 2024